Delivery Order SPE2DE24D0013-SPE2D625F3WBJ
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The Defense Department's Medical Supply Chain awarded a $25,920 firm fixed-price delivery order to Cepheid Inc. on September 9, 2025, with an ultimate completion date of September 16, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions from the Sunnyvale, California-based manufacturer, likely supporting testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection across federal healthcare systems. This award carries...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $25,200 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price contract, designated 4569285129 and titled XPCOV2/FLU/RSV-10, represents delivery of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and is scheduled for completion...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The Defense Logistics Agency's Medical Supply Chain division awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 13, 2025, with an ultimate completion date of August 20, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection. The contract carries no set-aside designation and is performed at Cepheid's facility in...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3WBJDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $2,040 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by September 25, 2025, and represents procurement of diagnostic testing supplies or equipment related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and is part of Cepheid's broader engagement with federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency, where the company serves as a primary supplier of GeneXpert diagnostic systems and associated molecular testing reagents. This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the VA, most notably the $32.8 billion IDV with Veterans Integrated Service Network 6 that extends through September 30, 2030. That larger vehicle enables continuous procurement of molecular diagnostic testing system reagents and assays for infectious disease detection across the VA's healthcare network. Cepheid's consistent award of such delivery orders reflects the company's established capability to supply critical diagnostic infrastructure and testing materials that support federal healthcare operations and pandemic preparedness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/18/25 |